Finance

Lists
IHH:KLSE
IHH Healthcare Bhd
7,94 MYR
-0,50%
(-0,040) 1D
16-окт., 09:20:16 GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for IHH...
Open
7,98 MYR
High
8,03 MYR
Low
7,93 MYR
Mkt. cap
70,16 млд
Avg. vol.
3,83 млн
Volume
68,60 миң
Dividend
1,39%
Quarterly dividend
0,03 MYR
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
31,25
52-wk high
9,58 MYR
52-wk low
7,54 MYR
EPS
0,25 MYR
Shares outstanding
8,84 млд
No. of employees
76 миң
Open
7,98 MYR
High
8,03 MYR
Low
7,93 MYR
Mkt. cap
70,16 млд
Avg. vol.
3,83 млн
Volume
68,60 миң
Dividend
1,39%
Quarterly dividend
0,03 MYR
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
31,25
52-wk high
9,58 MYR
52-wk low
7,54 MYR
EPS
0,25 MYR
Shares outstanding
8,84 млд
No. of employees
76 миң
News stories
From web sources and news partners
Profile
IHH Healthcare Berhad is a multinational private healthcare group headquartered in Singapore and Kuala Lumpur, Malaysia. The group operates 190 healthcare facilities, including 89 hospitals, across 10 countries and has a workforce of 76,000 employees across Singapore, Malaysia, Turkey, India, Greater China, and other regions of Asia and Europe. It is listed on Bursa Malaysia and the Singapore Exchange. As of FY24, the largest shareholder of IHH Healthcare is Mitsui of Japan followed by the Malaysian government's sovereign wealth fund Khazanah Nasional and Citigroup of the United States. A further stake is held by the Employees Provident Fund of Malaysia. The chairman of IHH is Nik Norzrul Thani bin N Hassan Thani. Wikipedia
About IHH Healthcare Bhd
CEOPrem Kumar Nair
Employees76 миң
Founded2010
Headquarters-
SectorHealth care provider
Last report
2026-ж., 27-авг.
Fiscal period
Q2 2026
0,06 MYR / 0,06 MYR
+7,33%beat
Revenue / Est. (MYR)
7,05 млд / 7,03 млд
+0,26%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in MYR
Loading Previous Earnings...
Revenue
Net income
All values in MYR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
6,57 млд
6,58 млд
6,55 млд
7,05 млд
Cost of goods sold
4,33 млд
4,34 млд
4,43 млд
4,76 млд
Cost of revenue
4,33 млд
4,34 млд
4,43 млд
4,76 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,00 млн
47,00 млн
38,00 млн
38,00 млн
Operating expense
1,20 млд
1,26 млд
1,17 млд
1,22 млд
Total operating expenses
5,53 млд
5,60 млд
5,60 млд
5,98 млд
Operating income
1,04 млд
983,00 млн
952,00 млн
1,07 млд
Other non operating income
-10,00 млн
-21,00 млн
-11,00 млн
-21,00 млн
EBT including unusual items
1,05 млд
886,00 млн
972,00 млн
1,03 млд
EBT excluding unusual items
808,00 млн
749,00 млн
743,00 млн
896,00 млн
Income tax expense
264,00 млн
260,00 млн
297,00 млн
309,00 млн
Effective tax rate
25,07%
29,35%
30,56%
29,94%
Other operating expenses
674,00 млн
621,00 млн
641,00 млн
640,00 млн
Net income
616,00 млн
528,00 млн
528,00 млн
573,00 млн
Net profit margin
9,38%
8,02%
8,06%
8,13%
Earnings per share
0,05
0,06
0,05
0,06
Interest and investment income
45,00 млн
39,00 млн
53,00 млн
96,00 млн
Interest expense
-269,00 млн
-252,00 млн
-252,00 млн
-252,00 млн
Net interest expenses
-224,00 млн
-213,00 млн
-199,00 млн
-156,00 млн
Depreciation and amortization charges
476,00 млн
474,00 млн
466,00 млн
490,00 млн
EBITDA
1,40 млд
1,36 млд
1,33 млд
1,50 млд
Gain or loss from assets sale
4,00 млн
-3,00 млн
-2,00 млн
-6,00 млн
AI content may include mistakes. Learn more
Google колдонмолору